With the success of the Human Genome sequencing project and increasing efforts toward association of human clinical conditions to DNA sequence variability, the desire and ability to develop assays that are diagnostic of a human condition is ever increasing.
Tepnel is committed to utilising advanced technologies in the development of easy-to-use reagents and kits for the detection of DNA sequence variation that is diagnostic of human disease.
The Elucigene™ brand is a well established range of products that have been extensively validated with many peer reviewed published references to support their application to human diagnostic and predisposition testing.
Elucigene products that incorporate fluorescent ARMS™ technology are available for rapid high throughput DNA testing. The availability of dedicated reporting software with fluorescent ARMS products provides laboratories with powerful tools for efficient and cost effective genotyping.
The Elucigene range currently includes kits and reagents for:
- Rapid aneuploidy testing
- Cystic Fibrosis screening
- Mutation screening of thirteen genetic diseases common in the Ashkenazi Jewish population
- Alpha-1-Antitrypsin mutation detection
- Predisposition testing for Deep Vein Thrombosis (DVT)
- Gaucher Disease mutation detection
- Familial Hypercholesterolemia genetic screening
Elucigene products are developed and manufactured by Tepnel Molecular Diagnostics in our facilities located in Oxfordshire, England. We are committed to continuing to expand the range of Elucigene products for disease mutation screening.
